trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['pantumor', 'trastuzumab-deruxtecan', 'rux,(-crux),(-trux)']
#asco23
#destiny pantumor02
trastuzumab-deruxtecan for her2 +2/3 dr. meric-bernstman 267 patients orr 37.1%, higher in #cervical #endometrial if her2 3+ orr 61.3% mdor 11.8m 12% ild promising results for #allsolid #her2 
Medical Oncologist MD, Vall d'Hebron @vallhebron @VHIO

Vocal Junta Govern @COMBarcelona

Asesor @SalutUIC
#GBM #PhaseI #oncology